Diagnostic and Staging Value of Serum Angiotensin-Converting Enzyme in Sarcoidosis
- PMID: 35242207
- PMCID: PMC8888048
- DOI: 10.1155/2022/4657502
Diagnostic and Staging Value of Serum Angiotensin-Converting Enzyme in Sarcoidosis
Retraction in
-
Retracted: Diagnostic and Staging Value of Serum Angiotensin-Converting Enzyme in Sarcoidosis.Comput Math Methods Med. 2023 Jun 28;2023:9785957. doi: 10.1155/2023/9785957. eCollection 2023. Comput Math Methods Med. 2023. PMID: 37416248 Free PMC article.
Abstract
Objective: To investigate the diagnostic and staging value of serum angiotensin-converting enzyme (sACE) in sarcoidosis.
Methods: Patients with suspected sarcoidosis treated in the Department of Pulmonary and Critical Care Medicine of the China-Japan Friendship Hospital from 2010 to 2020 were included. The data of sACE, erythrocyte sedimentation rate (ESR), complete blood count (CBC), lung function, bronchoalveolar lavage, and biopsy were collected. The differences between the sarcoidosis group and the nonsarcoidosis group and between different stages of sarcoidosis were compared. The receiver operating characteristic (ROC) curve analysis was used for the diagnostic test of sACE in sarcoidosis.
Results: A total of 84 cases with suspected sarcoidosis were included, among which 70 cases were confirmed to be sarcoidosis by biopsy. The mean value of sACE in sarcoidosis patients was 56.61 ± 30.80 U/L, which was significantly higher than that in nonsarcoidosis patients (28.07 ± 14.11 U/L, P = 0.001). The level of sACE in sarcoidosis patients with peripheral superficial lymph nodes and multiple system involvement was significantly higher than that in intrathoracic sarcoidosis patients (P = 0.009); the percentage of lymphocytes in bronchoalveolar lavage fluid (BALF) of sarcoidosis patients was 45.39 ± 22.87%, which was significantly higher than that of nonsarcoidosis patients (P < 0.001). There was no correlation between sACE and ESR (correlation coefficient = -0.167). According to ROC curve analysis, when sACE ≥ 44.0 U/L, the sensitivity of sarcoidosis diagnosis was 61.4%, the specificity was 92.9%, and the AUC was 0.819.
Conclusion: sACE has a good specificity in the diagnosis of sarcoidosis. sACE values in patients with sarcoidosis with systemic involvement were higher than those with simple intrathoracic sarcoidosis.
Copyright © 2022 Wenqiao Wang et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Performance of Serum Angiotensin-Converting Enzyme in Diagnosing Sarcoidosis and Predicting the Active Status of Sarcoidosis: A Meta-Analysis.Biomolecules. 2022 Sep 30;12(10):1400. doi: 10.3390/biom12101400. Biomolecules. 2022. PMID: 36291609 Free PMC article. Review.
-
Lack of correlation between serum angiotensin-converting enzyme activity and bronchoalveolar lymphocytosis in lung sarcoidosis.Eur J Respir Dis. 1984 Apr;65(3):189-95. Eur J Respir Dis. 1984. PMID: 6327344
-
Angiotensin-converting Enzyme as a Predictor of Extrathoracic Involvement of Sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 18;32(4):318-24. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 26847099
-
Pulmonary sarcoidosis: correlation of serum angiotensin-converting enzyme with blood and bronchoalveolar lymphocytes.Am Rev Respir Dis. 1982 Mar;125(3):366-9. doi: 10.1164/arrd.1982.125.3.366. Am Rev Respir Dis. 1982. PMID: 6279001
-
Serum angiotensin converting enzyme in sarcoidosis--its value in present clinical practice.Ann Clin Biochem. 1989 Jan;26 ( Pt 1):13-8. doi: 10.1177/000456328902600102. Ann Clin Biochem. 1989. PMID: 2544134 Review.
Cited by
-
SACE and IL-2R as serum biomarkers for evaluation of multi-organ involvement and prognosis of sarcoidosis.Respir Res. 2023 Sep 7;24(1):219. doi: 10.1186/s12931-023-02524-0. Respir Res. 2023. PMID: 37679741 Free PMC article.
-
Phenotypes and Serum Biomarkers in Sarcoidosis.Diagnostics (Basel). 2024 Mar 27;14(7):709. doi: 10.3390/diagnostics14070709. Diagnostics (Basel). 2024. PMID: 38611622 Free PMC article. Review.
-
Performance of Serum Angiotensin-Converting Enzyme in Diagnosing Sarcoidosis and Predicting the Active Status of Sarcoidosis: A Meta-Analysis.Biomolecules. 2022 Sep 30;12(10):1400. doi: 10.3390/biom12101400. Biomolecules. 2022. PMID: 36291609 Free PMC article. Review.
-
Retracted: Diagnostic and Staging Value of Serum Angiotensin-Converting Enzyme in Sarcoidosis.Comput Math Methods Med. 2023 Jun 28;2023:9785957. doi: 10.1155/2023/9785957. eCollection 2023. Comput Math Methods Med. 2023. PMID: 37416248 Free PMC article.
References
-
- Rizzato G., Palmieri G., Agrati A. M., Zanussi C. The organ-specific extrapulmonary presentation of sarcoidosis: a frequent occurrence but a challenge to an early diagnosis. A 3-year-long prospective observational study. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases . 2004;21:119–126. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous